Se L. Kim
Jeonju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The Combination of PF-543 and TRAIL Effectively Induces Apoptotic Cell Death and Inhibits Stem Cell-Like Properties Through the SPHK1/S1PR1/STAT3 Pathway in TRAIL-Resistant Colorectal Cancer Cells.
Journal: Digestive diseases and sciences
Published: March 26, 2025
Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors.
Journal: Digestive diseases and sciences
Published: May 03, 2024
HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: October 18, 2022
Lipocalin 2 activates the NLRP3 inflammasome via LPS‑induced NF‑κB signaling and plays a role as a pro‑inflammatory regulator in murine macrophages.
Journal: Molecular medicine reports
Published: July 12, 2022
Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathway.
Journal: Bioscience reports
Published: October 19, 2021
The HDAC1 Inhibitor CBUD-1001 Enhances TRAIL-induced Apoptosis in Colorectal Cancer Cells.
Journal: Anticancer research
Published: June 02, 2021
A novel HDAC1 inhibitor, CBUD‑1001, exerts anticancer effects by modulating the apoptosis and EMT of colorectal cancer cells.
Journal: International journal of oncology
Published: February 10, 2020
Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
Journal: International journal of oncology
Published: July 03, 2017
Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells.
Journal: Intestinal research
Published: April 08, 2016
MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
Journal: International journal of oncology
Published: January 12, 2016
Last Updated: 09/26/2026